|
1
|
Sia D and Villanueva A: Signaling pathways
in hepatocellular carcinoma. Oncology. 81(Suppl 1): 18–23. 2011.
View Article : Google Scholar
|
|
2
|
Earl TM and Chapman WC: Conventional
surgical treatment of hepatocellular carcinoma. Clin Liver Dis.
15:353–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen HP, Gong JP and Zuo GQ: Role of
high-intensity focused ultrasound in treatment of hepatocellular
carcinoma. Am Surg. 77:1496–1501. 2011.
|
|
4
|
Xu G, Luo G, He L, et al: Follow-up of
high-intensity focused ultrasound treatment for patients with
hepatocellular carcinoma. Ultrasound Med Biol. 37:1993–1999. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ai J, Biazar E, Jafarpour M, et al:
Nanotoxicology and nanoparticle safety in biomedical designs. Int J
Nanomedicine. 6:1117–1127. 2011.PubMed/NCBI
|
|
6
|
Oghabian MA and Farahbakhsh NM: Potential
use of nanoparticle based contrast agents in MRI: a molecular
imaging perspective. J Biomed Nanotechnol. 6:203–213. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang F, Li L, Li Y, Chen Z, Wu J and Gu N:
Superparamagnetic nanoparticle-inclusion microbubbles for
ultrasound contrast agents. Phys Med Biol. 53:6129–6141. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun J and Xie G: Tissue distribution of
intravenously administrated hydroxyapatite nanoparticles Labeled
with 125I. J Nanosci Nanotechnol. 11:10996–11000. 2011. View Article : Google Scholar
|
|
9
|
Li J, Yin Y, Yao F, Zhang L and Yao K:
Effect of nano- and micro-hydroxyapatite/chitosan-gelatin network
film on human gastric cancer cells. Mater Lett. 62:3220–3223. 2008.
View Article : Google Scholar
|
|
10
|
Visioli A, Rivens I, ter Haar G, et al:
Preliminary results of a phase I dose escalation clinical trial
using focused ultrasound in the treatment of localised tumours. Eur
J Ultrasound. 9:11–18. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Dubinsky TJ, Cuevas C, Dighe MK,
Kolokythas O and Hwang JH: High-intensity focused ultrasound:
current potential and oncologic applications. Am J Roentgenol.
190:191–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu T and Luo J: Adverse events of
extracorporeal ultrasound-guided high intensity focused ultrasound
therapy. PLoS One. 6:e261102011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu H, Zhou K, Zhang L, et al: High
intensity focused ultrasound (HIFU) therapy for local treatment of
hepatocellular carcinoma: Role of partial rib resection. Eur J
Radiol. 72:160–166. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kennedy JE, ter Haar GR, Wu F, et al:
Contrast-enhanced ultrasound assessment of tissue response to
high-intensity focused ultrasound. Ultrasound Med Biol. 30:851–854.
2004. View Article : Google Scholar
|
|
15
|
Choi D, Lim HK, Lee WJ, et al: Early
assessment of the therapeutic response to radio frequency ablation
for hepatocellular carcinoma utility of gray scale harmonic
ultrasonography with a microbubble contrast agent. J Ultrasound
Med. 22:1163–1172. 2003.
|
|
16
|
Hanajiri K, Maruyama T, Kaneko Y, et al:
Microbubble-induced increase in ablation of liver tumors by
high-intensity focused ultrasound. Hepatol Res. 36:308–314. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li C, Wu P, Liang Z, Fan W, Huang J and
Zhang F: Osteosarcoma: limb salvaging treatment by
ultrasonographically guided high-intensity focused ultrasound.
Cancer Biol Ther. 8:1102–1108. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu F, Wang Z-B, Chen W-Z, et al:
Extracorporeal high intensity focused ultrasound ablation in the
treatment of 1038 patients with solid carcinomas in China: an
overview. Ultrason Sonochem. 11:149–154. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu W, Xiao J, Wang D, et al: Experimental
study of nano-HA artificial bone with different pore sizes for
repairing the radial defect. Int Orthop. 33:567–571. 2009.
View Article : Google Scholar : PubMed/NCBI
|
